Association Between Obesity and COVID-19 Disease Severity in Saudi Population

References

• Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339–1340. doi:10.1001/jama.2020.3072
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit Care. 2020;24(1):516. doi:10.1186/s13054-020-03240-7
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Aleanizy FS, Alqahtani FY, Alanazi MS, et al. Clinical characteristics and risk factors of patients with severe COVID-19 in Riyadh, Saudi Arabia: a retrospective study. J Infect Public Health. 2021;14(9):1133–1138. doi:10.1016/j.jiph.2021.07.014
   PubMed Web of Science ®Google Scholar
• Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020;21(6):e13034. doi:10.1111/obr.13034
   PubMed Web of Science ®Google Scholar
• Zhang X, Lewis AM, Moley JR, Brestoff JR. A systematic review and meta-analysis of obesity and COVID-19 outcomes. Sci Rep. 2021;11(1):7193. doi:10.1038/s41598-021-86694-1
   PubMed Web of Science ®Google Scholar
• Yang J, Tian C, Chen Y, Zhu C, Chi H, Li J. Obesity aggravates COVID-19: an updated systematic review and meta-analysis. J Med Virol. 2021;93(5):2662–2674. doi:10.1002/jmv.26677
   PubMed Web of Science ®Google Scholar
• Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195–1199. doi:10.1002/oby.22831
   PubMed Web of Science ®Google Scholar
• Caussy C, Pattou F, Wallet F, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020;8(7):562–564. doi:10.1016/S2213-8587(20)30160-1
   PubMed Web of Science ®Google Scholar
• Malik P, Patel U, Patel K, et al. Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis. J Med Virol. 2021;93(2):1188–1193. doi:10.1002/jmv.26555
   PubMed Web of Science ®Google Scholar
• Zhao X, Gang X, He G, et al. Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis. Front Endocrinol. 2020;11:595109. doi:10.3389/fendo.2020.595109
   PubMed Web of Science ®Google Scholar
• Soffer S, Zimlichman E, Glicksberg BS, et al. Obesity as a mortality risk factor in the medical ward: a case control study. BMC Endocr Disord. 2022;22(1):13. doi:10.1186/s12902-021-00912-5
   Web of Science ®Google Scholar
• Fezeu L, Julia C, Henegar A, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev. 2011;12(8):653–659. doi:10.1111/j.1467-789X.2011.00864.x
   PubMed Web of Science ®Google Scholar
• Samprathi M, Jayashree M. Biomarkers in COVID-19: an up-to-date review. Front Pediatr. 2021;8. doi:10.3389/fped.2020.607647
   Web of Science ®Google Scholar
• Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. Markers of chronic inflammation in overweight and obese individuals and the role of gender: a Cross-Sectional Study of a large cohort. J Inflamm Res. 2021;14:567–573. doi:10.2147/JIR.S294368
   PubMed Web of Science ®Google Scholar
• Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755–767. doi:10.1080/17476348.2018.1506331
   PubMed Web of Science ®Google Scholar
• Umbrello M, Fumagalli J, Pesenti A, Pathophysiology CD. Management of acute respiratory distress syndrome in obese patients. Semin Respir Crit Care Med. 2019;40(1):40–56. doi:10.1055/s-0039-1685179
   Web of Science ®Google Scholar
• Andrade FB, Gualberto A, Rezende C, Percegoni N, Gameiro J, Hottz ED. The weight of obesity in immunity from influenza to COVID-19. Front Cell Infect Microbiol. 2021;11:638852. doi:10.3389/fcimb.2021.638852
   PubMed Web of Science ®Google Scholar
• Zhang F, Xiong Y, Wei Y, et al. Obesity predisposes to the risk of higher mortality in young COVID-19 patients. J Med Virol. 2020;92(11):2536–2542. doi:10.1002/jmv.26039
   Web of Science ®Google Scholar
• Noyola DE, Hermosillo-Arredondo N, Ramirez-Juarez C, Werge-Sanchez A. Association between obesity and diabetes prevalence and COVID-19 mortality in Mexico: an Ecological study. J Infect Dev Ctries. 2021;15(10):1396–1403. doi:10.3855/jidc.15075
   Web of Science ®Google Scholar
• Zhang J, Xu Y, Shen B, et al. The association between obesity and severity in patients with coronavirus disease 2019: a retrospective, single-center study, Wuhan. Int J Med Sci. 2021;18(8):1768–1777. doi:10.7150/ijms.54655
   Web of Science ®Google Scholar
• Hendren NS, de Lemos JA, Ayers C, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular disease registry. Circulation. 2021;143(2):135–144. doi:10.1161/CIRCULATIONAHA.120.051936
   PubMed Web of Science ®Google Scholar
• Recalde M, Roel E, Pistillo A, et al. Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. Int J Obes. 2021;45(11):2347–2357. doi:10.1038/s41366-021-00893-4
   Web of Science ®Google Scholar
• Kooistra EJ, de Nooijer AH, Claassen WJ, et al. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes. 2021;45(3):687–694. doi:10.1038/s41366-021-00747-z
   Web of Science ®Google Scholar
• Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA, et al. Obesity in Saudi Arabia. Saudi Med J. 2005;26(5):824–829.
   PubMed Web of Science ®Google Scholar
• Alqarni SSM. A review of prevalence of obesity in Saudi Arabia. J Obes Eat Disord. 2016;2:25. doi:10.21767/2471-8203.100025
   Google Scholar
• World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases; 2020.
   Google Scholar
• WHO Consultation on Obesity, World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation; 2000:0512–3054.
   Google Scholar
• World Health Organization. Clinical Management of COVID-19: Interim Guidance. Geneva: World Health Organization; 2020.
   Google Scholar
• Cheng WA, Turner L, Marentes Ruiz CJ, et al. Clinical manifestations of COVID-19 differ by age and obesity status. Influenza Other Respi Viruses. 2022;16(2):255–264. doi:10.1111/irv.12918
   Web of Science ®Google Scholar
• Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020;71(15):896–897. doi:10.1093/cid/ciaa415
   PubMed Web of Science ®Google Scholar
• Hajifathalian K, Kumar S, Newberry C, et al. Obesity is associated with worse outcomes in COVID-19: analysis of early data from New York city. Obesity. 2020;28(9):1606–1612. doi:10.1002/oby.22923
   PubMed Web of Science ®Google Scholar
• Cruz-Lagunas A, Jimenez-Alvarez L, Ramirez G, et al. Obesity and pro-inflammatory mediators are associated with acute kidney injury in patients with A/H1N1 influenza and acute respiratory distress syndrome. Exp Mol Pathol. 2014;97(3):453–457. doi:10.1016/j.yexmp.2014.10.006
   Web of Science ®Google Scholar
• Venkata C, Sampathkumar P, Afessa B. Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clin Proc. 2010;85(9):798–805. doi:10.4065/mcp.2010.0166
   Web of Science ®Google Scholar
• Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One. 2010;5(3):e9694. doi:10.1371/journal.pone.0009694
   PubMed Web of Science ®Google Scholar
• Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York city health system. JAMA. 2020;324(8):799–801. doi:10.1001/jama.2020.13372
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Zheng KI, Gao F, Wang XB, et al. Letter to the Editor: obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism. 2020;108:154244. doi:10.1016/j.metabol.2020.154244
   PubMed Web of Science ®Google Scholar
• Wang F, Hou H, Luo Y, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020;5:10. doi:10.1172/jci.insight.137799
   Web of Science ®Google Scholar
• Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–215. doi:10.1016/S2213-8587(14)70134-2
   PubMed Web of Science ®Google Scholar
• Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004;110(12):1564–1571. doi:10.1161/01.CIR.0000142055.53122.FA
   PubMed Web of Science ®Google Scholar
• Sattar N, Valabhji J. Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care. Curr Obes Rep. 2021;10(3):282–289. doi:10.1007/s13679-021-00448-8
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950–2973. doi:10.1016/j.jacc.2020.04.031
   PubMed Web of Science ®Google Scholar
• Rosito GA, D’Agostino RB, Massaro J, et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost. 2004;91(4):683–689. doi:10.1160/TH03-01-0014
   Web of Science ®Google Scholar
• Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687. doi:10.1093/cvr/cvaa106
   PubMed Web of Science ®Google Scholar
• Gong MN, Bajwa EK, Thompson BT, Christiani DC. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax. 2010;65(1):44–50. doi:10.1136/thx.2009.117572
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
   PubMed Web of Science ®Google Scholar
• Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a Whole-Population study. Lancet Diabetes Endocrinol. 2020;8(10):813–822. doi:10.1016/S2213-8587(20)30272-2
   PubMed Web of Science ®Google Scholar
• Bailly L, Fabre R, Courjon J, Carles M, Dellamonica J, Pradier C. Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study. Clin Microbiol Infect. 2022;28(1):114–123. doi:10.1016/j.cmi.2021.09.010
   Web of Science ®Google Scholar